Friday , 22 November 2024
Home Health PEPFAR’s Short-Term Reauthorization Sets an Uncertain Course for Its Long-Term Future
Health

PEPFAR’s Short-Term Reauthorization Sets an Uncertain Course for Its Long-Term Future

PEPFAR’s Short-Term Reauthorization Sets an Uncertain Course for Its Long-Term Future

With the new omnibus bill, PEPFAR has been reauthorized until March 25, 2025, without the inclusion of any controversial provisions or changes related to abortion, sought by some. Still, while this latest step provides the program with some short-term certainty, including signaling bipartisan support (albeit limited), it marks a significant departure from PEPFAR’s past.

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

Kura Oncology Gets $330M to Kick Off Global Leukemia Drug Pact With Kyowa Kirin

Kura Oncology already had a broad development plan for ziftomenib in leukemias,...

How Much More Would People Pay in Premiums if the ACA’s Enhanced Subsidies Expired?

Enhanced Affordable Care Act (ACA) subsidies lower premium payments for ACA Marketplace...

Everything You Need to Know About Hip Replacement Surgery in India

Hip replacement surgery is one of the most common and successful medical...

Speculation on RFK Jr. as HHS Secretary

From Tyler Cowen at Marginal Revolution: One of the problems with an...